RedHill Biopharma RDHL Peer Comparison

NASDAQ RDHL
$0.68 +0.02 (+3.59%)
As of: Sep 9, 2026 · 2:10 PM EDT
Peer Comparison

300 Comparable Companies

Industry Generic Drugs

RedHill Biopharma Ltd. (RDHL) is the 272nd largest of 300 Generic Drugs companies by market capitalisation, at 176.59 Mn, behind Quince Therapeutics, Inc. at 181.53 Mn. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 TEVA Teva Pharmaceutical Industries Ltd primary H-04 Pharmaceuticals and Biotechnology HG-01 42.61 Bn 61.22 2.46 38.95 Bn
2 VTRS Viatris Inc primary H-04 Pharmaceuticals and Biotechnology HG-01 19.18 Bn -46.71 1.30 18.30 Bn
3 RDY Dr Reddys Laboratories Ltd primary H-04 Pharmaceuticals and Biotechnology HG-01 9.85 Bn 780.84 2.69 9.68 Bn
4 AMRX Amneal Pharmaceuticals, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 5.48 Bn 25.45 1.76 5.35 Bn
5 BHC Bausch Health Companies Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 2.36 Bn -2.16 0.22 0.52 Bn
6 ALVO Alvotech primary H-04 Pharmaceuticals and Biotechnology HG-01 1.50 Bn -5.40 4.38 1.36 Bn
7 ANIP Ani Pharmaceuticals Inc primary H-04 Pharmaceuticals and Biotechnology HG-01 1.49 Bn 13.78 1.52 1.13 Bn
8 AMPH Amphastar Pharmaceuticals, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.99 Bn 11.91 1.36 0.70 Bn
9 FENC Fennec Pharmaceuticals Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -91.42 7.54 0.36 Bn
10 RDHL RedHill Biopharma Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -434.89 37.17 0.18 Bn
11 NTRB NutriBand Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -10.02 43.13 0.07 Bn
12 BGM BGM Group Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.03 Bn — — 0.02 Bn
13 ETST Earth Science Tech, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 6.76 0.72 0.02 Bn
14 NXPL NextPlat Corp primary H-04 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.48 0.51 0.01 Bn
15 COSM Cosmos Health Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.78 0.22 0.01 Bn
16 SCNX Scienture Holdings, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.92 36.02 0.01 Bn
17 AEON AEON Biopharma, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.24 — 0.01 Bn
18 PMHS Polomar Health Services, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.59 1.78 0.01 Bn
19 SXTP 60 Degrees Pharmaceuticals, Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.38 2.23 0.00 Bn
20 SBFM Sunshine Biopharma Inc. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.27 0.04 -0.01 Bn
21 QNRX Quoin Pharmaceuticals, Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
22 PRFX PRF Technologies Ltd. primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.18 53.74 -0.01 Bn
23 GRMLW Greenland Mines Ltd primary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 — -0.01 Bn
24 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 646.71 Bn 30.74 6.60 625.95 Bn
25 ABBV AbbVie Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 442.22 Bn 70.02 6.87 435.65 Bn
26 MRK Merck & Co., Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 366.92 Bn 115.78 5.51 359.78 Bn
27 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 211.73 Bn 24.22 5.56 197.75 Bn
28 ABT Abbott Laboratories secondary H-06 Medical Devices and Diagnostics HG-02 184.08 Bn 33.93 3.95 178.48 Bn
29 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 181.27 Bn -62.62 5.95 178.09 Bn
30 PFE Pfizer Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 159.20 Bn 36.45 2.50 147.50 Bn
31 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 132.28 Bn 30.03 10.51 124.42 Bn
32 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 82.76 Bn 19.12 5.33 74.77 Bn
33 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 61.59 Bn 35.91 11.79 56.41 Bn
34 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 54.65 Bn -17.34 24.53 49.52 Bn
35 SNY Sanofi secondary H-01 Pharmaceuticals and Biotechnology HG-01 52.44 Bn 11.25 0.98 45.06 Bn
36 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 33.96 Bn 43.84 7.07 30.66 Bn
37 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 31.22 Bn 37.41 3.11 29.93 Bn
38 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 29.94 Bn -20.17 2,741.06 29.94 Bn
39 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 28.15 Bn -32.16 24.75 26.99 Bn
40 INCY Incyte Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 25.38 Bn 15.74 4.36 20.85 Bn
41 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 23.67 Bn -13.89 7.65 10.02 Bn
42 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 18.27 Bn 21.56 2.15 17.86 Bn
43 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.89 Bn 18.33 11.21 14.95 Bn
44 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.84 Bn -49.64 12.33 15.00 Bn
45 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.58 Bn 22.08 4.62 15.19 Bn
46 JAZZ Jazz Pharmaceuticals plc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.11 Bn 16.06 3.28 13.50 Bn
47 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.91 Bn -21.55 20.91 14.19 Bn
48 EXEL Exelixis, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 14.52 Bn 16.87 5.96 13.68 Bn
49 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.66 Bn — — 12.97 Bn
50 BAX Baxter International Inc secondary H-07 Medical Devices and Diagnostics HG-02 12.81 Bn 557.12 1.15 10.66 Bn
51 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.59 Bn 30.44 7.57 12.36 Bn
52 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.58 Bn 172.35 3.69 11.70 Bn
53 CORT Corcept Therapeutics Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 12.15 Bn 224.07 14.62 11.84 Bn
54 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 11.95 Bn -43.90 17.84 10.34 Bn
55 AAVXF Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
56 AXSM Axsome Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.88 Bn -70.78 14.01 10.56 Bn
57 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
58 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.14 Bn -26.59 — 9.38 Bn
59 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.09 Bn 18.84 3.21 9.49 Bn
60 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.54 Bn 86.43 33.84 9.54 Bn
61 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.33 Bn -43.94 10.67 7.27 Bn
62 GPCR Structure Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 9.07 Bn -48.22 — 9.07 Bn
63 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.55 Bn -8.09 — 8.55 Bn
64 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.42 Bn -8.48 50.77 8.06 Bn
65 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.97 Bn -14.80 — 7.97 Bn
66 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.73 Bn 17.50 9.67 7.05 Bn
67 GIFLF Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
68 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.48 Bn -41.79 — 7.48 Bn
69 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.13 Bn -17.66 — 7.13 Bn
70 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.93 Bn -32.95 28.87 6.60 Bn
71 BLCO Bausch & Lomb Corp secondary H-06 Medical Devices and Diagnostics HG-02 6.45 Bn -39.57 1.21 6.07 Bn
72 HIMS Hims & Hers Health, Inc. secondary H-16 Healthcare Providers HG-04 6.43 Bn -45.26 2.49 5.59 Bn
73 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.34 Bn -707.43 4,551.55 6.34 Bn
74 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.31 Bn -28.14 1,012.57 6.31 Bn
75 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.31 Bn -7.33 10.20 5.87 Bn
76 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.14 Bn 76.13 7.30 5.61 Bn
77 LQDA Liquidia Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 6.08 Bn 43.84 13.47 5.79 Bn
78 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.92 Bn -16.01 — 5.92 Bn
79 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.86 Bn -33.28 1,166.98 5.68 Bn
80 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.86 Bn -16.15 — 5.86 Bn
81 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.82 Bn 29.52 20.04 4.47 Bn
82 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.77 Bn — — 4.04 Bn
83 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.61 Bn 14.68 5.57 3.39 Bn
84 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.00 Bn -17.40 — 5.00 Bn
85 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.97 Bn -22.69 — 4.97 Bn
86 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.09 Bn -8.00 1,135.11 4.09 Bn
87 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.03 Bn — — 3.62 Bn
88 TLPPF Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 4.64 3.59 Bn
89 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.86 Bn -18.47 11.88 3.56 Bn
90 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.85 Bn -13.46 371.89 3.85 Bn
91 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.80 Bn -7.11 — 3.80 Bn
92 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.66 Bn -30.11 — 3.66 Bn
93 OGN Organon & Co. secondary H-01 Pharmaceuticals and Biotechnology HG-01 3.59 Bn 17.19 0.59 2.46 Bn
94 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.58 Bn -7.79 30.63 2.88 Bn
95 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.56 Bn -34.74 66.07 2.54 Bn
96 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.55 Bn -16.13 15.16 2.72 Bn
97 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.41 Bn -20.74 51.60 3.41 Bn
98 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.21 Bn -6.21 — 3.21 Bn
99 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.12 Bn 109.68 6.73 2.89 Bn
100 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.03 Bn -9.85 19,154.55 3.03 Bn
101 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.98 Bn -11.02 593.06 2.46 Bn
102 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.95 Bn -14.66 — 2.95 Bn
103 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.92 Bn -28.03 — 2.92 Bn
104 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.91 Bn -8.53 79.19 2.47 Bn
105 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.83 Bn -15.01 6.29 2.12 Bn
106 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.65 Bn -81.77 — 2.65 Bn
107 TAK Takeda Pharmaceutical Co Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.62 Bn 4.56 0.06 -3.18 Bn
108 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.56 Bn -8.46 49.20 2.56 Bn
109 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.56 Bn -172.82 10.18 2.45 Bn
110 BEIGF BeOne Medicines Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.40 -2.62 Bn
111 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.46 Bn -6.15 — 2.46 Bn
112 SUPN Supernus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.43 Bn -28.53 3.08 2.06 Bn
113 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.41 Bn -20.30 44.18 1.73 Bn
114 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.41 Bn -6.03 33.89 2.41 Bn
115 HRMY Harmony Biosciences Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.41 Bn 13.51 2.51 1.60 Bn
116 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.33 Bn -17.02 1.18 1.54 Bn
117 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.31 Bn -6.02 4.33 1.96 Bn
118 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -2,975.41 — 2.29 Bn
119 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -3.90 — 2.02 Bn
120 NUVB Nuvation Bio Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.28 Bn -21.06 13.40 2.28 Bn
121 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn -36.46 12.03 2.16 Bn
122 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.25 Bn -11.33 — 1.88 Bn
123 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.15 Bn 0.17 0.34 0.65 Bn
124 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.14 Bn -8.83 — 2.14 Bn
125 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.13 Bn 12.83 4.17 2.00 Bn
126 AUPH Aurinia Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.11 Bn 6.71 6.77 1.66 Bn
127 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.09 Bn -15.20 104.25 2.09 Bn
128 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -5.06 21.18 2.08 Bn
129 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.07 Bn -5.25 — 2.07 Bn
130 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.03 Bn -4.89 2,033.48 2.03 Bn
131 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.00 Bn -13.32 53.81 1.73 Bn
132 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.96 Bn -9.43 71.00 1.67 Bn
133 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.90 Bn -11.62 18.08 1.52 Bn
134 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.82 Bn -13.67 1,402.38 1.82 Bn
135 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.81 Bn -7.18 5.96 1.81 Bn
136 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.78 Bn -98.29 4.13 0.90 Bn
137 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.76 Bn -9.70 6.97 1.21 Bn
138 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.74 Bn -124.58 17.59 1.74 Bn
139 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn -3.34 31.55 1.18 Bn
140 GLPGF Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
141 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -26.97 — 1.32 Bn
142 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.64 Bn -6.22 — 1.10 Bn
143 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.62 Bn -6.55 3.92 0.90 Bn
144 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.62 Bn -192.89 938.23 1.61 Bn
145 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -8.62 — 1.60 Bn
146 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn -10.36 525.18 1.59 Bn
147 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn -66.54 7.98 1.30 Bn
148 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
149 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.54 Bn -9.11 20.12 1.26 Bn
150 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.50 Bn -3.24 2.09 1.21 Bn
151 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -17.49 — 1.47 Bn
152 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -9.49 50.87 0.83 Bn
153 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -13.62 72.21 1.44 Bn
154 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.44 Bn -26.55 5.57 1.03 Bn
155 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -9.67 — 1.44 Bn
156 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.41 Bn -8.62 — 1.41 Bn
157 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.41 Bn -4.74 — 1.41 Bn
158 HROW Harrow, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.41 Bn -42.05 5.10 1.32 Bn
159 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.39 Bn 81.67 36.28 1.39 Bn
160 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.39 Bn -11.48 890.25 1.19 Bn
161 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -9.84 — 1.37 Bn
162 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -8.66 — 1.36 Bn
163 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.32 Bn -6.46 — 1.32 Bn
164 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -1.39 — 1.28 Bn
165 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.27 Bn -5.25 152.66 0.77 Bn
166 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.23 Bn -28.14 3.12 1.12 Bn
167 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -11.91 50.93 1.22 Bn
168 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -25.49 — 1.00 Bn
169 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.17 Bn -7.64 — 1.17 Bn
170 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.15 Bn -20.00 — 1.15 Bn
171 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.14 Bn -4.72 23.40 0.68 Bn
172 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn -3.86 — 0.49 Bn
173 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 6.65 5.58 0.92 Bn
174 OKYO OKYO Pharma Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.00 Bn -118.02 — 1.00 Bn
175 WVE Wave Life Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.98 Bn -4.82 14.93 0.61 Bn
176 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -69.87 — 0.92 Bn
177 GERN Geron Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -14.19 3.92 0.65 Bn
178 ARDX Ardelyx, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -17.08 2.11 0.67 Bn
179 ANNX Annexon, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.90 Bn -4.38 — 0.90 Bn
180 TBPH Theravance Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 20.85 8.45 0.49 Bn
181 RIGL Rigel Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.87 Bn 2.71 3.15 0.78 Bn
182 STTK Shattuck Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.82 Bn -15.12 816.31 0.82 Bn
183 AVTX Avalo Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.80 Bn -8.02 — 0.80 Bn
184 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -9.93 96.12 0.79 Bn
185 VSTM Verastem, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -6.79 8.94 0.65 Bn
186 CTMX CytomX Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -10.22 42.35 0.44 Bn
187 PHAR Pharming Group N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.77 Bn -124.40 2.32 0.61 Bn
188 ZURA Zura Bio Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn -6.19 — 0.72 Bn
189 ZVRA Zevra Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.72 Bn 12.34 5.28 0.50 Bn
190 AURA Aura Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.69 Bn -6.27 — 0.62 Bn
191 IRWD Ironwood Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn 3.04 1.73 0.59 Bn
192 CRMD CorMedix Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 5.06 1.70 0.38 Bn
193 SLN Silence Therapeutics plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -16.37 1,034.60 0.56 Bn
194 ASMB Assembly Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.62 Bn 500.44 8.32 0.30 Bn
195 CBIO Crescent Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -3.77 591.25 0.44 Bn
196 ALT Altimmune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -8.32 — 0.61 Bn
197 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -344,822.34 — 0.60 Bn
198 VALN Valneva SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -9.89 3.46 0.44 Bn
199 ARVN Arvinas, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn 61.66 1.81 0.01 Bn
200 CTNM Contineum Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.49 — 0.57 Bn
201 TECX Tectonic Therapeutic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -6.66 — 0.57 Bn
202 SGMT Sagimet Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -11.79 — 0.57 Bn
203 BBOT BridgeBio Oncology Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -2.84 — 0.34 Bn
204 FLGT Fulgent Genetics, Inc. secondary H-17 Healthcare Providers HG-04 0.56 Bn -6.60 2.31 0.30 Bn
205 OVID Ovid Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -15.54 338.65 0.42 Bn
206 IMUX Immunic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -4.51 — 0.52 Bn
207 OABI OmniAb, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -11.59 13.35 0.46 Bn
208 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -7.45 22.40 0.22 Bn
209 CNTN Canton Strategic Holdings, Inc. secondary T-58 Fintech TG-09 0.48 Bn -5.89 330.55 0.48 Bn
210 PRTA Prothena Corp Public Ltd Co secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn -11.01 8.86 0.20 Bn
211 KMDA Kamada Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 15.23 2.47 0.40 Bn
212 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -10.27 78.36 0.24 Bn
213 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.85 — 0.45 Bn
214 RLMD Relmada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -7.63 — 0.47 Bn
215 CYPH Cypherpunk Technologies Inc. secondary T-58 Fintech TG-09 0.47 Bn 7.83 — 0.47 Bn
216 PBYI Puma Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 15.32 1.98 0.37 Bn
217 CCCC C4 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.47 12.92 0.20 Bn
218 DRUG Bright Minds Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -15.32 — 0.45 Bn
219 AVIR Atea Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -3.09 — 0.42 Bn
220 ARCT Arcturus Therapeutics Holdings Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -4.44 14.38 0.23 Bn
221 RZLT Rezolute, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -5.14 — 0.42 Bn
222 CMPX Compass Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -5.10 — 0.42 Bn
223 BIOA BioAge Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -4.33 39.23 0.41 Bn
224 LRMR Larimar Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -2.29 — 0.25 Bn
225 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.11 38.94 0.19 Bn
226 ENTA Enanta Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -6.07 5.87 0.19 Bn
227 EYPT EyePoint, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -1.23 136.84 0.20 Bn
228 HMDCF HUTCHMED (China) Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
229 OCGN Ocugen, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.37 Bn -4.53 80.97 0.27 Bn
230 OFIX Orthofix Medical Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.36 Bn -8.34 0.44 0.26 Bn
231 CATX Perspective Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -3.01 — 0.36 Bn
232 WHWK Whitehawk Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn -4.33 — 0.35 Bn
233 FHTX Foghorn Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -5.13 9.16 0.27 Bn
234 EPRX Eupraxia Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -6.52 — 0.33 Bn
235 ELDN Eledon Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.87 — 0.32 Bn
236 UPB Upstream Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -1.98 100.05 0.32 Bn
237 CLLS Cellectis S.A. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -7.42 5.23 0.14 Bn
238 STRO Sutro Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -2.68 3.39 0.14 Bn
239 TRDA Entrada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -1.81 63.95 0.30 Bn
240 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 3.12 2.16 0.29 Bn
241 SABS SAB Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -4.12 — 0.28 Bn
242 BCYC Bicycle Therapeutics Plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.48 4.60 0.28 Bn
243 ACIU AC Immune SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -5.19 12.69 0.28 Bn
244 TLSI TriSalus Life Sciences, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.28 Bn -4.77 6.21 0.23 Bn
245 EQ Equillium, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -15.39 — 0.28 Bn
246 FIXX Q32 Bio Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 67.73 — 0.16 Bn
247 GALT Galectin Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -9.65 — 0.27 Bn
248 ALXO Alx Oncology Holdings Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -3.21 — 0.26 Bn
249 AKBA Akebia Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -8.76 1.19 0.10 Bn
250 ALEC Alector, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -2.95 18.69 0.09 Bn
251 MGNX Macrogenics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -16.06 1.54 0.14 Bn
252 CYDY CytoDyn Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -7.61 — 0.26 Bn
253 AVXL Anavex Life Sciences Corp. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -18.22 — 0.14 Bn
254 CAMP Camp4 Therapeutics Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -5.09 60.46 0.25 Bn
255 IVVD Invivyd, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.02 4.51 0.09 Bn
256 ANTX AN2 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -7.00 — 0.25 Bn
257 KRRO Korro Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -2.88 99.85 0.12 Bn
258 TARA Protara Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -3.36 — 0.24 Bn
259 CGEN Compugen Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 6.66 3.17 0.15 Bn
260 CELG-RI Bristol Myers Squibb Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.02 0.00 -10.84 Bn
261 PYXS Pyxis Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.42 16.27 0.19 Bn
262 GLSI Greenwich LifeSciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -10.10 — 0.23 Bn
263 NMRA Neumora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.38 — 0.22 Bn
264 KROS Keros Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.47 6.78 -0.04 Bn
265 PEPG PepGen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -3.08 — 0.22 Bn
266 SRZN Surrozen, Inc./DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -3.61 19.13 0.22 Bn
267 TNXP Tonix Pharmaceuticals Holding Corp. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.35 7.40 0.22 Bn
268 ABOS Acumen Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -2.03 — 0.21 Bn
269 PLX Protalix BioTherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 10.03 2.63 0.17 Bn
270 PRQR ProQR Therapeutics N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -4.33 9.92 0.08 Bn
271 FTH Faeth Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.06 — 0.21 Bn
272 ARMP Armata Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -3.32 — 0.18 Bn
273 DERM Journey Medical Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -56.25 3.02 0.18 Bn
274 CHRS Coherus Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.55 4.03 0.10 Bn
275 ORGO Organogenesis Holdings Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.20 Bn -2.01 0.44 0.15 Bn
276 ACOG Alpha Cognition Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -7.29 14.95 0.16 Bn
277 ADCT ADC Therapeutics SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -1.35 2.64 -0.02 Bn
278 VYGR Voyager Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -2.41 5.75 0.08 Bn
279 ORMP Oramed Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn 1.14 — 0.19 Bn
280 CUE Cue Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.92 8.64 0.18 Bn
281 ADAG Adagene Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -13.14 32.66 0.19 Bn
282 SLGL Sol-Gel Technologies Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -18.22 106.45 0.14 Bn
283 NBP NovaBridge Biosciences secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -2.47 — 0.19 Bn
284 IPHA Innate Pharma SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.14 60.09 0.18 Bn
285 QNCX Quince Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.41 — 0.18 Bn
286 MOLN Molecular Partners Ag secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.51 214.11 0.18 Bn
287 XLO Xilio Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -5.52 2.70 0.04 Bn
288 OKUR OnKure Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -2.72 — -0.01 Bn
289 RANI Rani Therapeutics Holdings, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -4.86 32.70 0.16 Bn
290 MDWD MediWound Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -5.07 13.28 0.12 Bn
291 NGEN Nervgen Pharma Corp. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -116.03 — 0.16 Bn
292 MIST Milestone Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn — — -0.02 Bn
293 ENTX Entera Bio Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -10.35 — 0.14 Bn
294 MSLE Satellos Bioscience Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -2.90 — 0.15 Bn
295 IFRX InflaRx N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 1,813.85 -0.04 Bn
296 SPRB Spruce Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.87 — 0.14 Bn
297 UNCY Unicycive Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -4.98 — 0.14 Bn
298 IBIO iBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -3.99 1,316.36 0.13 Bn
299 HURA TuHURA Biosciences, Inc./NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.26 — 0.13 Bn
300 CNTB Connect Biopharma Holdings Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -1.89 44.08 0.13 Bn